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Abstract
Purpose Brazil is the largest country in South America. Although a developing nation, birth rates have been decreasing in the last
few decades, while its overall population is undergoing lifestyle changes and ageing significantly. Moreover, Brazil has had
increasingly high mortality rates related to colorectal cancer (CRC). Herein, we investigated whether the Brazilian population is
exhibiting increasing mortality rates related to colon cancer (CC) or rectal cancer (RC) in recent years.
Methods We examined data from the Brazilian Federal Government from 1979 to 2015 to determine whether CRCmortality and
the population ageing process may be associated.
Results Our mathematical modelling suggests that mortality rates related to CC and RC events in the Brazilian population may
increase by 79% and 66% in the next 24 years, respectively. This finding led us to explore the mortality rates for both diseases in
the country, and we observed that the highest levels were in the south and southeast regions from the year 2000 onwards. CC
events appear to decrease life expectancy among people during their second decade of life in recent years, whereas RC events
induced decreases in life expectancy in those aged >30 years. Additionally, both CC and RC events seem to promote significant
mortality rates in the male population aged > 60 years and living in the southern states.
Conclusion Our dataset suggests that both CC and RC events may lead to a significantly increasing number of deaths in the
Brazilian male population in coming years.
Keywords Ageing . Cancermortality . Epidemiology . Lifestyle
Introduction
Colorectal cancer (CRC) is currently reported as one of the
leading causes of cancer-related deaths worldwide, in males
and females [1]. One should consider that CRC terminology
comprises two types of cancer with similar risk factors: colon
cancer (CC) and rectal cancer (RC). The colon has two ana-
tomical components referred to as the proximal and distal,
which respectively connects this organ to the small intestine
and the rectum. The rectum connects the distal colon to the
anal sphincter [2]. Both CC and RC have significant genetic
similarities regarding the mutations promoting their develop-
ment. Symptoms are quite similar for both diseases, although
bleeding in CC patients may be observed in brown or black
colours, while RC events are related to brighter red bleedings.
Because of anatomical patterns, RC is prone to metastasize to
the thorax, bones, and nervous system, while the peritoneum
seems to be a recurrent target for CC metastases. Also, cancer
recurrence seems to be more frequent in RC patients.
Moreover, RC events seem to be somewhat more common
in men than women [3]. We should stress that because
aetiology and risk factors are almost the same for both CC
and RC events, they are generally widely known together as
CRC [1, 2, 4, 5].
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Until the first half part of the last century, CRC was a rather
rare disease even in countries currently with high rates [4].
Considering that most CRC cases are sporadic in aetiology,
changes in lifestyle across the globe could thus be directly
linked to the increasing incidence of this disease [1, 4, 6–8].
Although an uncountable number of factors may augment
CRC rates in a given human cohort, ageing of the worldwide
population may play the most pivotal role in this disease
aetiology and can be considered one of the primary mecha-
nisms driving the CRC development [5]. For instance, most
CRC incidence and mortality occurs in elderly populations
living in developed countries [6].
In keeping with this idea, Kuipers et al. observed that the
average lifetime risk for CRC might be up to 5% in a general
population set without a family history for the disease. In cases
where a first-degree family member >50 years old has been
diagnosed with CRC, this lifetime risk may double, while it
could even triple if the first-degree relative were <50 years of
age by the time of diagnosis [4]. However, on analysing CRC
rates in Americans aged <50 years old, an increasing inci-
dence of this disease in the younger US adult population is
revealed [7, 9]. Interestingly, it has been reported that CRC
incidence declined in the USA, generally [1]. On the contrary,
another study suggests that about 60% of CRC cases will be
found in developing countries by the year 2030 [8].
Brazil is the largest country in South America and
has the fifth largest population worldwide. The elderly
Brazilian population has been projected to achieve 64
million seniors by 2050 [10]. The country also faces
significant social inequality among its elderly citizens,
a factor that may impact on the incidence of chronic
diseases and healthcare costs shortly [11]. The CRC
incidence in Brazilians aged less than 50 years old has
also been reported increased by 35% in recent years
[12]. Although developed countries have shown a sig-
nificant decrease in CRC death rates [1], the Brazilian
population endured increased numbers of CRC-related
deaths for the last 30 years [13]. In as much as CRC
mortality rates vary in between different Brazilian states,
a factor closely related to the economic development of
each region, CRC mortality rates have significantly in-
creased over recent years in the country [14]. These
facts raise some concern that the Brazilian population
could have a significant increase in CRC-related rates
for both incidence and mortality soon, meaning that
epidemiological studies on what regions have recently
had the highest CRC mortality rates in the country are
in significant need now. Herein, we studied the trend
for CC and RC mortality during the next 24 years (from
2016 up to 2040), verified mortality rates for both dis-
eases in different Brazilian regions throughout 36 years,
as well as studied recent mortality rates according to
age and gender.
Material and Methods
Data Collection
CRC mortality data were obtained from the Mortality
Information System (SIM) of the Brazilian Ministry of
Health, while population-based data were collected from the
Brazilian Institute of Geography and Statistics (IBGE).
According to the International Classification of Diseases
(10th revision, ICD-10) for CC (ICD-10, C18) and RC mor-
tality rates (ICD-10, C19–21), mortality data were collected
from 1979 to 2015 on an annual basis. According to the same
timeframe, population-based data were also collected. This
period has been chosen to further explore previous findings
on CRC mortality rates in Brazil.
To statistically compare the Brazilian regions with the
highest CRC mortality rates among themselves (Midwest
[MW], Southeast [SE], and South regions [S]), we collected
data that provides from regional health centres (RHCs).
According to SIM, RHCs are government units responsible
for coordinating the activities of the State Health Secretariat at
the regional level of each Brazilian state. Thus, each Brazilian
region is composed of different states with multiple RHCs in
each one: Midwest region (Federal capital region [DF] had 1
RHC, Goias state [GO] had 16 RHCs, Mato Grosso do Sul
[MS] had 12 RHCs, and Mato Grosso [MT] had 16 RHCs),
Southeast region (Espirito Santo [ES] had 4 RHCs, Minas
Gerais [MG] had 16 RHCs, Rio de Janeiro [RJ] had 9
RHCs, and Sao Paulo [SP] had RHCs), and South region
(Parana [PR] had 16 RHCs, Santa Catarina [SC] had 16
RHCs, and Rio Grande do Sul [RS] had 16 RHCs).
Statistical Analyses
Prospective values for mortality from 2016 until 2040
were calculated according to a prediction function m(y)
described as follows:
m yð Þ ¼ f yð Þ dp yð Þ
dy
dps yð Þ
dy
 −1 o65 yð Þ
o65 2015ð Þ ð1Þ
where f(y) is a second-order polynomial function fitted
to proportional mortality rates (PMR) recorded between
the years y (1979 and 2015). This function represents
the mortality growth regardless of factors such as pop-
ulation growth and ageing. Then, p(y) is a second-order
polynomial function fitted to the official estimate of the
Brazilian population between 2014 and 2016. This func-
tion represents how a population will grow over time.
To this end, ps(y) is a linear function fitted to the offi-
cial records of the Brazilian population between 2010
and 2015, which represents the population growth in
the years anticipating the future estimation. We should
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also consider that o65(y) is the official percentage of
people >65 years for the year y, while o65(2015) is
the percentage of people >65 years in 2015 (the year
that recorded data ends). The mortality function de-
scribed in Eq. 1 was therefore adjusted to take into
consideration variations in population growth and age-
ing over time. In summary, 1% of CC or RC mortality
rates calculated by Eq. 1 means that 1% of the deaths
in a determined year was caused by one of these
diseases.
CC and RC mortality values were calculated as PMR, as
described by Swaroop and Uemura [15]. One should note that
any potential misclassification at diagnosis was not exposure-
dependent, cause of death is precisely registered, all deaths are
included, and population comparisons are consistent within
the study [16]. According to Romeder and McWhinnie [17],
years of potential life lost (YPLL) per 100,000 were deter-
mined by the number of deaths in the Brazilian population
across different age ranges (between 15 and 79 years old) from
1979 to 2015. This calculation provides age-adjusted rates
within a closed population. We further calculate the age-
adjusted death rates (AADR) per 100,000 related to CC and
RC events, according to the previous description of
Yerushalmy (1951) [18]. These values were determined based
on data from the regional health centres (RHCs) within each
Brazilian state in the Midwest, Southeast, and South regions.
Values have been adjusted to the Brazilian population of 2010.
Data analyses determined differences in mortality rates re-
lated to CC and RC events across different time points in
various Brazilian regions by employing a two-way ANOVA
model followed by the correction of multiple comparisons
through the control of false discovery rates according to the
two-stage step-up method of Benjamini, Krieger, and
Yekutieli. These analyses were performed on MATLAB
R2014b (MathWorks, Inc., Natick, MA, USA) and
GraphPad Prism 8.1.0 (GraphPad, San Diego, CA, USA). P
values of <0.05 were considered significant.
Results
CC and RCMortality Across Different Brazilian Regions
from 1979 to 2015
First, we analysed the mortality rates related to CC and RC
events in Brazil.We observed that the number of deaths by CC
and RC increased 2.8-fold and 3.1-fold throughout the last
36 years, respectively. Indeed, our mathematical modelling
projected an upward trend in mortality for both diseases in
the forthcoming 24 years (CC, from 6.2 to 7.8 per 100,000;
RC, from 3.6 to 5.4 per 100,000; Fig. 1; Table 1).
This prospective analysis led us to investigate mortality
rates by CC and RC in different regions of the country. Our
dataset shows that the population living in the MW, SE, and S
regions of Brazil exhibit a significant increase in CC and RC
mortality rates in recent years when compared with the inhab-
itants of the North (N) and Northeast (NE) regions (Fig. 2).
We also observe that RC-related mortality in the MW popu-
lation increased to a level no different from that of the SE
region (Fig. 2c, d). Whether CC-related mortality is higher
Fig. 1 Mortality rates related to colon (CC) and rectal cancer (RC) in
Brazil. While the recorded period (1979–2015) is shown as continuous
lines for both diseases, dashed lines represent the data collected from
perspective calculations between 2016 and 2040
Table 1 Colon cancer
(CC) and rectal cancer
(RC) mortality rates per
100,000 in Brazil
Year CC-related
mortality
RC-related
mortality
2010 4.71 2.80
2012 4.95 2.92
2014 5.35 3.12
2016 6.20 3.33
2018 6.61 3.66
2020 7.06 4.02
2022 7.52 4.39
2024 8.00 4.79
2026 8.46 5.18
2028 8.87 5.55
2030 9.19 5.87
2032 9.38 6.11
2034 9.39 6.22
2036 9.16 6.17
2038 8.64 5.92
2040 7.80 5.42
Values shown herein represent the record-
ed period between 2010 and 2014 for both
CC and RC mortality rates, while a math-
ematical modelling projects these events
from 2016 until 2040
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in the S region than in the SE, no difference has been found for
death rates related to RC events between both areas (Fig. 2).
Effects of Ageing on CC and RC Mortality in Recent
Years
To better understand these events, we calculated the impact on
life expectancy due to CC and RC events in the Brazilian
population. Both CC and RC elevated the most shortening
in life expectancy between the years 2009 and 2015 (Fig. 3).
We further found that the decrease in life expectancy associ-
ated with CC started during the second decade of life, while
RC induced similar effects in subjects not younger than
30 years old (Fig. 3).
We then calculatedmortality rates adjusted by age to clarify
these concerning findings in recent years. The AADR for male
and female inhabitants from the MW, SE, and S regions of
Brazil between 2014 and 2015 reveal that southern men and
women aged 70 years old or more exhibited higher mortality
rates related to CC than those living in the SE andMWregions
(Fig. 4). While southern men in their seventieth decade of life
onwards had the highest RC mortality rates, this same effect
appeared to occur in the female population aged ≥80 years old
(Fig. 5). Indeed, the southern male population died more fre-
quently of CC and RC than women following their seventieth
decade of life (Figs. 4 and 5). Similar differences between
male and female populations for CC and RC mortality rates
are observed in the SE region (Figs. 4 and 5). Irrespective of
whether the MW male population exhibited the highest CC
mortality rates following their eightieth decade of life (Fig. 4),
RC promoted the highest mortality among female inhabitants
of this area (Fig. 5).
Studying the MW states, we found that the oldest male and
female populations living in the Federal District (DF) had the
highest CC and CRC mortality rates in the region (Figs. 4 and
5). Interestingly, those men aged 70 years old or more and
residing in the state of Mato Grosso (MT) showed the lowest
values of CC and RC mortality (Figs. 4 and 5).
In the SE region, men aged ≥80 years old and living in the
states of São Paulo (SP) and Rio de Janeiro (RJ) showed the
highest CC and RC mortality rates (Figs. 4 and 5). It seems
that the old male population in the state of Espirito Santo (ES)
had the lowest values of RC mortality (Fig. 4). In comparison
with the states of São Paulo (SP) and Rio de Janeiro (RJ),
women residing in the state of Minas Gerais (MG) had lower
rates of CC and RC mortality (Figs. 4 and 5). Indeed, the male
population living in the state of SP died more of CC and RC
than women from 70 years old age onwards (Fig. 5).
Following the seventieth decade of life, both men and
women living in the southern state of Rio Grande do Sul
Fig. 2 Mortality rates for colon
cancer (CC) and rectal cancer
(RC) in Brazil. a and b Heatmaps
illustrate proportional mortality
rates (PMR) for CC (a) and RC
(b) according to a population of
100,000 people in different re-
gions of Brazil (North [N];
Northeast [NE]; Midwest [MW];
Southeast [SE]; South [S]) from
1979 until 2015. Whether bright
green colours represent the lowest
mean values of proportional mor-
tality rates (PMR) in each
Brazilian region, bright red col-
ours represent the highest values.
c and d Scatter dot plots show P
values that have been calculated
by the two-way ANOVA model
followed by correction of multi-
ple comparisons through the con-
trol of false discovery rates ac-
cording to the two-stage step-up
method of Benjamini, Krieger,
and Yekutieli
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(RS) had the highest mortality rates of CC in the region
(Fig. 4). Whether the Rio Grande do Sul (RS) male population
had the highest mortality values due to RC events (Fig. 5),
women living in the state of Parana (PR) showed the highest
mortality for this disease when compared to the female popu-
lation of other southern states (Fig. 5).
Discussion
Cancer mortality rates for both CC and RC cases have signif-
icantly increased over the years in Brazil. One should note that
CC mortality was higher than RC-related deaths. Since RC
events have been widely associated with poor patient survival
[3], we believe that the Brazilian population has a higher in-
cidence of CC than RC-related events. Arnold and colleagues
have analysed CC and RC mortality rates in 42 countries and
reported similar findings to ours in Brazil [19].
Our findings also suggest that CC and RC mortality rates
may rise even higher in the coming years. This finding is in
keeping with what has been reported by previous studies for a
time range similar to ours [8, 19, 20]. Moreover, Jemal and
colleagues predicted the number of CRC-related deaths
worldwide (881,000 events) and ranked this disease second
among the malignancies most related to fatal cases in 2018
[1]. Indeed, increased incidence and mortality rates of this
disease have been suggested as a marker of socioeconomic
development [1]. Bray et al. suggest that Brazil is one of those
nations where CRC incidence and mortality have increased in
recent years [1].
In contrast, countries observed to have a decreasing inci-
dence and mortality rates have been the USA, Japan, and
France [21]. In the USA and Japan, this effect could partially
be related to the implementation of long-standing screening
and early detection programmes against CRC [22]. However,
food-related issues promoting obesity in the younger
American adult population has also been suggested to be as-
sociated with increasing CRC incidence in patients aged <
50 years old [7, 9].
Analysing CC and RC mortality rates over time and across
different Brazilian regions suggests that potential changes in
lifestyle have occurred in recent years. This notion seems
more evident when analysing YPLL rates found in the
Brazilian population. One should consider that changes in
Fig. 3 Years of potential life lost
(YPLL) due to colon cancer (CC)
and rectal cancer (RC) events in
Brazil. a and b Heatmaps illus-
trate YPLL values for CC (a) and
RC (b) are shown in different
populations with age ranging
from 15 to 79 years old between
1979 and 2015 in Brazil. Whether
bright green colours represent the
lowest mean values of YPLL,
bright red colours represent the
highest values. c and d Scatter dot
plots show P values that have
been calculated by the two-way
ANOVA model followed by cor-
rection of multiple comparisons
through the control of false dis-
covery rates according to the two-
stage step-up method of
Benjamini, Krieger, and Yekutieli
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diet, body weight, and lifestyle could explain trends towards
high CRC incidence, while best practices in cancer manage-
ment and treatment may reduce mortality for this disease [21].
Besides the fact that a sound healthcare system decreases the
number of cancer-related deaths, lifestyle profoundly impacts
on both cancer risk and survival of patients. India seems to
illustrate how changes in lifestyle impacts on CRC incidence
and mortality. GLOBOCAN-based studies show that whether
CRC incidence and mortality were lower in India than in Brazil
by 2012 [21], analysing the same patterns 6 years later high-
lights a significant elevation of this disease in the Indian male
population [1]. An Indian research group recently suggested
that healthier lifestyle habits could reduce CRC incidence in
the country [23]. In Brazil, research groups have been reporting
frequent physical inactivity in the younger population, increas-
ingly high intakes of red meat, and low consumption of fruits
overall [24–27]. Folgueira and colleagues analysed 88 cases of
gastric cancer and found that poor eating habits could be related
to the development of this malignancy in younger adults living
in Brazil [28].
The Brazilian population living in the southern regions of
the country appear to exhibit the highest mortality rates for
both CC and RC events. The male inhabitants of these
Brazilian states may have a much higher mortality risk by
either CC or RC than the female population. The Rio
Grande do Sul (RS) state has previously been found to have
the highest CRCmortality rates in Brazil [14]. Bray et al. have
recently reported that the male population has a 50% higher
chance of dying by any type of cancer than women worldwide
[1]. A previous study carried out in the RS state revealed CRC
to be the most prevalent type of cancer in both sexes com-
bined, as prostate malignancies are the most common in men
Fig. 4 Age-adjusted death rates (AADR) related to colon cancer events (CC)
during the year of 2015 are shown for both male (M) and female populations
(F) living in different Brazilian states according to their regional location in
the country. aAADR values related to CC are shown in different populations
with age ranging from 20 to 80 years old during the year of 2015 in Brazil.
These values were determined based on data from regional health centres
(RHCs) within each Brazilian state in the Midwest (MW; Federal capital
region [DF; RHC=1], Goias state [GO; RHC= 16], and Mato Grosso do
Sul [MS; RHC= 12] and Mato Grosso [MT; RHC=16] states), Southeast
(SE; Espirito Santo [ES; RHC=4], Minas Gerais [MG; RHC=16], Rio de
Janeiro [RJ; RHC= 9], and Sao Paulo [SP; RHC= 16] states), and South
regions (S; Parana [PR; RHC= 16], Santa Catarina [SC; RHC= 16], and
Rio Grande do Sul [RS; RHC= 16]). Values have been adjusted to the
Brazilian population of 2010. Whether bright green colours represent the
lowest mean values of AADR in each Brazilian region, bright red colours
represent the highest values. b Scatter dot plots show P values that have been
calculated by the two-wayANOVAmodel followed by correction ofmultiple
comparisons through the control of false discovery rates according to the two-
stage step-up method of Benjamini, Krieger, and Yekutieli
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and breast cancer in women [29]. Although heredity impact on
CRC risk even in Brazil [30], two independent studies have
shown that only specific rare mutations may impact a small
percentage of the Brazilian population in general [31–33].
Assunção and colleagues reported that processed meats are
now consumed very regularly by the Rio Grande do Sul
(RS) inhabitants [34]. The Brazilian population seems to have
acquired unhealthy eating habits in recent years [24, 25, 27,
28]. Consumption of red or processed meat seems to be an
established risk factor promoting CRC [35]. Since the imple-
mentation of longer-standing screening and early detection
programmes, CRC mortality seems to have decreased in other
countries [22]. Frasca and colleagues report that testing for
faecal occult blood could provide a significant strategy for
early detection of CRC in the Brazilian population [36].
We must further consider that the Brazilian population is
rapidly ageing and that this process has the potential to in-
crease the risk of cancer besides the threat imposed by an
unhealthy lifestyle [5, 10]. Recent studies have demonstrated
that ageing decreases proliferation rates but increases the mu-
tational load in humans or any other given organism [37, 38].
Although these findings seem controversial at first sight,
DeGregori suggested that ageing provides the required length
of time required for oncogenic mutations to accumulate and
cancer to arise in a particular body site [39]. While the
Brazilian population is undergoing significant changes in life-
style factors to closely mirror those in developed Western
societies, expansion of its elderly population is coupled with
a lack of efficient anticancer health programmes reported to
lower CRC incidence in developedWestern regions [1, 10, 11,
Fig. 5 Age-adjusted death rates (AADR) related to rectal cancer events (RC)
during the year of 2015 are shown for both male (M) and female populations
(F) living in different Brazilian states according to their regional location in
the country. aAADR values related to RC are shown in different populations
with age ranging from 20 to 80 years old during the year of 2015 in Brazil.
These values were determined based on data from regional health centres
(RHCs) within each Brazilian state in the Midwest (MW; Federal capital
region [DF; RHC=1], Goias state [GO; RHC= 16], and Mato Grosso do
Sul [MS; RHC= 12] and Mato Grosso [MT; RHC=16] states), Southeast
(SE; Espirito Santo [ES; RHC=4], Minas Gerais [MG; RHC=16], Rio de
Janeiro [RJ; RHC= 9], and Sao Paulo [SP; RHC= 16] states), and South
regions (S; Parana [PR; RHC= 16], Santa Catarina [SC; RHC= 16], and
Rio Grande do Sul [RS; RHC= 16]). Values have been adjusted to the
Brazilian population of 2010. Whether bright green colours represent the
lowest mean values of AADR in each Brazilian region, bright red colours
represent the highest values. b Scatter dot plots show P values that have been
calculated by the two-wayANOVAmodel followed by correction ofmultiple
comparisons through the control of false discovery rates according to the two-
stage step-up method of Benjamini, Krieger, and Yekutieli
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13, 20, 40]. Thus, it is no surprise that we report herein in-
creasing CC and CRCmortality in this Brazil region currently
and in the coming decades. The current Brazilian scenario
unfortunately seems to be set ideally for exponential increases
in CRC incidence and mortality in the coming decades.
Although our findings are in keeping with previous national
and international forecasting that CRC incidence and mortality
rates would increase in Brazil [8, 20], this current study has
some limitations that should be considered. First, we must con-
sider that the period required for data consolidation in a public
database results in a few years gap from the time that death
events have been registered until the release of data to the
public. This secondary data usage further limits the study de-
sign, as well as the interpretation of these results at an individ-
ual level. Moreover, registration errors at SIM can, in a hypo-
thetical scenario, lead to under- or overestimation of incidence
and mortality rates of any given disease. Nevertheless, mortal-
ity trends can also be slightly modified in case new diagnostic
and therapeutic guidelines are implemented in the country dur-
ing the predicted time-lapse [13, 20, 40, 41].
Our current findings suggest that mortality rates for CC and
RC are rapidly rising throughout many Brazilian regions. This
scenario may worsen in the coming years, as Brazilians are read-
ily acquiring dietary and lifestyle habits fromWestern developed
countries that have a consistent pattern for high incidence and
mortality related to CRC. The most needed attention regarding
healthcare strategy in treatment and prevention should be given
to the inhabitants of the RS state, as high rates of CC and RC
mortality have been observed here for consecutive decades now.
New studies on cancer-related deaths in the RS state are required
now, as future findings may help to decrease mortality rates for
other types of cancer in different regions of Brazil.
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